Keyphrases
Chanzyme
100%
Neuroinflammation
100%
Therapeutic Potential
100%
Protein Family
100%
Alzheimer's Disease
100%
Reactive Microglia
18%
5xFAD
18%
Plaque
18%
Carvacrol
18%
Inflammatory Activity
12%
Disease-associated
12%
Microglial Activation
12%
Therapeutic Agents
12%
Glial Activation
6%
Transgenic Animals
6%
Inflammatory Microglia
6%
Microglia Phenotype
6%
Alzheimer's Disease Brain
6%
Memory Function
6%
Phenotypic Change
6%
Clinical Trials
6%
Unsatisfactory Outcome
6%
Phosphorylated tau
6%
Small Interfering RNA (siRNA)
6%
Anti-Alzheimer Drugs
6%
Alzheimer's Disease Treatment
6%
Drug Development
6%
Most Common Form
6%
Molecular Mechanism
6%
Alzheimer's Disease Model
6%
Therapeutic Strategies
6%
Ca2+ Influx
6%
Translocated
6%
Amyloid beta
6%
Kinase Domain
6%
FTY720
6%
New Drug Development
6%
Microglia
6%
Drug Target
6%
Morris Water Maze
6%
Microglial Cells
6%
Dementia
6%
Medicine and Dentistry
Protein Subfamily
100%
Neuroinflammation
100%
Alzheimer's Disease
100%
Microglia
43%
Carvacrol
18%
Oligomer
12%
Therapeutic Agent
12%
Fingolimod
6%
Transgenic Animal
6%
Water Maze
6%
Amyloid Beta
6%
Clinical Trial
6%
Calcium Ion
6%
Small Interfering RNA
6%
In Vitro
6%
Tau
6%
Phosphotransferase
6%
Anti-Inflammatory Drug
6%
Combination Therapy
6%
Pharmacology, Toxicology and Pharmaceutical Science
Nervous System Inflammation
100%
Alzheimer's Disease
100%
Carvacrol
23%
Drug Development
15%
5xFAD Mouse
15%
Oligomer
15%
Transgenic Animal
7%
Phosphotransferase
7%
Fingolimod
7%
Clinical Trial
7%
Calcium Ion
7%
Small Interfering RNA
7%
Combination Therapy
7%
Anti-Inflammatory Drug
7%
Amyloid Protein
7%